Funding
| 1 |
Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result. |
| … in terms of IPR protection |
| It is copyright protected (no cost) |
| …in terms of product development |
| Around 100.000€, concerning software re-engineering |
| …in terms of mass production |
| Around 30.000€, concerning manual and documentation |
| … in terms of marketing |
| Around 100.000€ for leaflets, advertising in specialized magazines and web sites, participation in relevant exhibitions, events etc… |
| 2 |
Based on the above assessment as well as the marketing information please provide the correct estimation of the price for R&D product in correlation with costs |
|
Year 1 |
Year 2 |
Year 3 |
Year 4 |
Year 5 |
| Fixed costs |
50.000 |
50.000 |
50.000 |
50.000 |
50.000 |
| Personnel |
255.000 |
250.000 |
375.000 |
375.000 |
375.000 |
| Other running costs |
20.000 |
40.000 |
50.000 |
50.000 |
50.000 |
| Marketing costs |
30.000 |
50.000 |
10.000 |
10.000 |
10.000 |
| TOTAL EXPECTED COSTS |
355.000 |
390.000 |
485.000 |
485.000 |
485.000 |
| Price per Unit |
50.000 |
50.000 |
50.000 |
50.000 |
50.000 |
| Type of Unit |
Digital platform |
| Number of Units |
5 |
10 |
15 |
15 |
15 |
| TOTAL Expected Revenues |
250.000 |
500.000 |
750.000 |
750.000 |
750.000 |
| CASH FLOW REQUIRED (REVENUES-COSTS) |
-105.000 |
|
|
|
|
| TOTAL CAPITAL required for five years |
105.000 |
SECTION 2: QUALITATIVE FACTORS
| 4 |
Dimension of identified target groups |
| Considering a target of 600 incubators, i.e. 15% of the number of incubators globally, targeting probably to a specific geographical area, we assume that the market finally gained is 60 units, thus meaning the 10% of the target market. |
| 6 |
Evaluation of financial Risks for R&D result |
| Detailed comment
As a new product to the market, there is a possibility that the market might not be mature enough to accept it. Also the geographical diversity of the users is an obstacle to the product’s promotion. Assuming that sales during the first year is an unachievable goal and taking into account that for every new product we have 25.000€ personnel cost regarding customization and installation, the financial risk for the first year will be around 230.000€. |
SECTION 3: IDENTIFICATION OF FINANCING SOURCES
After evaluating all the above mentioned criteria, please tick the best financing source for the achievement of R&D result (i.e. own capitals, banking credits, venture capital, business angels, etc)
| 1 European Funding |
| 1. The respective R&D result has been developed through EU support (INTERREG III B) and no further support is envisaged for it.
|
| 2 National Funding |
| 1. National Innovation Programs, for example National Strategic Reference Framework (ESPA) could be used for development and marketing costs |
| 3 Private funding |
| 1. Joint venture with potential investor |
| 4 Other |
| |
SECTION 3: FINAL EVALUATION
| It is requested a final evaluation considering the funding opportunities you believe most suitable for the exploitation of the R&D result, considering the possibility of the creation of a spin-off, further research, in particular, a cost/benefit analysis and a financial projection for the R&D result, type of collaboration identified (i.e. Licensing Agreement, Technical Cooperation, Joint Venture, Manufacturing Agreement, Commercial Agreement with Technical Assistance, Creation of a spin-off, Joint further development)… |
| The creation of a spin-off, based on joint agreement for technology, licensing and market exploitation, is under consideration although a joint venture with a private investor would be much appreciated. |
Decision of evaluation
- The R&D has a high potential of exploitation
- The R&D result needs minor revisions
Bookmark the
permalink. Follow any comments here with the
RSS feed for this post.
or leave a trackback:
Trackback URL.
Panagiotis Tsarchopoulos
Isidoros Passas
